Did you know that something as simple as feeling out of breath could be a silent alarm for a serious lung condition? World COPD Day, observed on November 19, 2025, shines a spotlight on this often-overlooked health issue, and the Queensland chapter of the Pharmacy Guild of Australia is urging everyone to take action. But here's where it gets interesting: many people brush off breathlessness as just a sign of getting older, not realizing it could be an early warning of chronic obstructive pulmonary disease (COPD).
COPD is a progressive lung disease that, when caught early and managed properly, can significantly improve a person’s quality of life and slow its advancement. The key lies in recognizing the symptoms before they worsen, and that’s where community pharmacists come in. Cate Whalan, Senior Vice President of the Guild’s Queensland branch, emphasizes, ‘Community pharmacists are not just medication dispensers; they’re accessible health advocates who can help you spot the signs of COPD early and guide you in managing your lung health effectively.’
And this is the part most people miss: pharmacists aren’t just there for prescriptions—they’re trained to provide personalized advice and support, making them a vital resource in the fight against COPD. But here’s a thought-provoking question: Are we fully utilizing these healthcare professionals in our communities, or are we overlooking their potential to improve public health?
This article, originally published in Pharmacy Daily on November 19, 2025, also highlights other critical developments in the pharmaceutical world. Public consultation has wrapped up for the Pharmaceutical Society of Australia’s (PSA) new Continuing Professional Development (CPD) standards, marking a significant step forward in ensuring pharmacists stay at the top of their game. Meanwhile, ARROTEX Pharmaceuticals has introduced ARX-Telmisartan/Amlodipine, a new hypertension treatment now listed on the Pharmaceutical Benefits Scheme (PBS).
Lastly, as World AMR Awareness Week kicks off, the global health community is rallying to combat antimicrobial resistance (AMR), a growing threat fueled by drug-resistant pathogens. But here’s a controversial take: Are we doing enough to address AMR, or are we merely scratching the surface of a much larger problem?
What’s your take? Do you think pharmacists are underutilized in public health, or are we on the right track? And how concerned are you about the rise of AMR? Share your thoughts in the comments—let’s spark a conversation that could shape the future of healthcare.
